These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 30182766)

  • 1. Insights into possibilities for grouping and read-across for nanomaterials in EU chemicals legislation.
    Mech A; Rasmussen K; Jantunen P; Aicher L; Alessandrelli M; Bernauer U; Bleeker EAJ; Bouillard J; Di Prospero Fanghella P; Draisci R; Dusinska M; Encheva G; Flament G; Haase A; Handzhiyski Y; Herzberg F; Huwyler J; Jacobsen NR; Jeliazkov V; Jeliazkova N; Nymark P; Grafström R; Oomen AG; Polci ML; Riebeling C; Sandström J; Shivachev B; Stateva S; Tanasescu S; Tsekovska R; Wallin H; Wilks MF; Zellmer S; Apostolova MD
    Nanotoxicology; 2019 Feb; 13(1):119-141. PubMed ID: 30182766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk assessment of nanomaterials in cosmetics: a European union perspective.
    Henkler F; Tralau T; Tentschert J; Kneuer C; Haase A; Platzek T; Luch A; Götz ME
    Arch Toxicol; 2012 Nov; 86(11):1641-6. PubMed ID: 23052193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Grouping of nanomaterials to read-across hazard endpoints: from data collection to assessment of the grouping hypothesis by application of chemoinformatic techniques.
    Lamon L; Asturiol D; Richarz A; Joossens E; Graepel R; Aschberger K; Worth A
    Part Fibre Toxicol; 2018 Sep; 15(1):37. PubMed ID: 30249272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Grouping of nanomaterials to read-across hazard endpoints: a review.
    Lamon L; Aschberger K; Asturiol D; Richarz A; Worth A
    Nanotoxicology; 2019 Feb; 13(1):100-118. PubMed ID: 30182776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory aspects of nanotechnology in the agri/feed/food sector in EU and non-EU countries.
    Amenta V; Aschberger K; Arena M; Bouwmeester H; Botelho Moniz F; Brandhoff P; Gottardo S; Marvin HJ; Mech A; Quiros Pesudo L; Rauscher H; Schoonjans R; Vettori MV; Weigel S; Peters RJ
    Regul Toxicol Pharmacol; 2015 Oct; 73(1):463-76. PubMed ID: 26169479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Weight of Evidence approach to classify nanomaterials according to the EU Classification, Labelling and Packaging Regulation criteria.
    Basei G; Zabeo A; Rasmussen K; Tsiliki G; Hristozov D
    NanoImpact; 2021 Oct; 24():100359. PubMed ID: 35559818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A critical appraisal of existing concepts for the grouping of nanomaterials.
    Arts JH; Hadi M; Keene AM; Kreiling R; Lyon D; Maier M; Michel K; Petry T; Sauer UG; Warheit D; Wiench K; Landsiedel R
    Regul Toxicol Pharmacol; 2014 Nov; 70(2):492-506. PubMed ID: 25108058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of REACH: Issues Involved in the Registration of Metals.
    Armstrong V; Karyakina NA; Nordheim E; Arnold I; Krewski D
    Neurotoxicology; 2021 Mar; 83():186-198. PubMed ID: 32057950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PBT assessment using the revised annex XIII of REACH: a comparison with other regulatory frameworks.
    Moermond CT; Janssen MP; de Knecht JA; Montforts MH; Peijnenburg WJ; Zweers PG; Sijm DT
    Integr Environ Assess Manag; 2012 Apr; 8(2):359-71. PubMed ID: 22006646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuating risks through regulation: issues for nanotechnology in India.
    Barpujari I
    J Biomed Nanotechnol; 2011 Feb; 7(1):85-6. PubMed ID: 21485816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grouping and Read-Across Approaches for Risk Assessment of Nanomaterials.
    Oomen AG; Bleeker EA; Bos PM; van Broekhuizen F; Gottardo S; Groenewold M; Hristozov D; Hund-Rinke K; Irfan MA; Marcomini A; Peijnenburg WJ; Rasmussen K; Jiménez AS; Scott-Fordsmand JJ; van Tongeren M; Wiench K; Wohlleben W; Landsiedel R
    Int J Environ Res Public Health; 2015 Oct; 12(10):13415-34. PubMed ID: 26516872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human health safety evaluation of cosmetics in the EU: a legally imposed challenge to science.
    Pauwels M; Rogiers V
    Toxicol Appl Pharmacol; 2010 Mar; 243(2):260-74. PubMed ID: 20006634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Environmental Risk Assessment of Technical Mixtures Under the European Registration, Evaluation, Authorisation and Restriction of Chemicals-A Regulatory Perspective.
    Galert W; Hassold E
    Integr Environ Assess Manag; 2021 May; 17(3):498-506. PubMed ID: 33448633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updating the European Union's regulation on classification, labelling and packaging of substances and mixtures (CLP): A key opportunity for consumers, workers and stakeholders with interests in the legislation and toxicology of hazardous chemicals.
    Vinceti SR; Docea AO; Tsitsimpikou C; Filippini T
    Toxicol Rep; 2021; 8():1865-1868. PubMed ID: 34824981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The use of nanotechnology in medicinal products in the light of European Union law].
    Jurewicz M
    Pol Merkur Lekarski; 2014 Dec; 37(222):369-72. PubMed ID: 25715580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In the shadow of the Cosmetic Directive--inconsistencies in EU environmental hazard classification requirements for UV-filters.
    Sobek A; Bejgarn S; Rudén C; Molander L; Breitholtz M
    Sci Total Environ; 2013 Sep; 461-462():706-11. PubMed ID: 23770551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Necessity and approach to integrated nanomaterial legislation and governance.
    Wang J; Gerlach JD; Savage N; Cobb GP
    Sci Total Environ; 2013 Jan; 442():56-62. PubMed ID: 23178764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The changes in hazard classification and product notification procedures of the new European CLP and Cosmetics Regulations.
    de Groot R; Brekelmans P; Herremans J; Meulenbelt J
    Clin Toxicol (Phila); 2010 Jan; 48(1):28-33. PubMed ID: 20055632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Background of REACH in EU regulations on evaluation of chemicals.
    Foth H; Hayes A
    Hum Exp Toxicol; 2008 Jun; 27(6):443-61. PubMed ID: 18784197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ECETOC Florence workshop on risk assessment of endocrine substances, including the potency concept.
    Fegert I
    Toxicol Lett; 2013 Dec; 223(3):310-4. PubMed ID: 23558296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.